Documente Academic
Documente Profesional
Documente Cultură
Correspondence to
Dr. van de Beek:
d.vandebeek@amc.uva.nl
ABSTRACT
Methods: We assessed the incidence, clinical characteristics, and outcome of patients with bacterial
meningitis presenting with a minimal score on the Glasgow Coma Scale from a nationwide cohort
study of adults with community-acquired bacterial meningitis in the Netherlands from 2006 to 2012.
Results: Thirty of 1,083 patients (3%) presented with a score of 3 on the Glasgow Coma Scale. In
22 of 30 patients (73%), the minimal Glasgow Coma Scale score could be explained by use of
sedative medication or complications resulting from meningitis such as seizures, cerebral edema,
and hydrocephalus. Systemic (86%) and neurologic (47%) complications occurred frequently,
leading to a high proportion of patients with unfavorable outcome (77%). However, 12 of 30 patients (40%) survived and 7 patients (23%) had a good functional outcome, defined as a score of
5 on the Glasgow Outcome Scale. Patients presenting with a minimal Glasgow Coma Scale score
on admission and bilaterally absent pupillary light responses, bilaterally absent corneal reflexes,
or signs of septic shock on admission all died.
Conclusions: Patients with community-acquired bacterial meningitis rarely present with a minimal
score on the Glasgow Coma Scale, but this condition is associated with high rates of morbidity
and mortality. However, 1 out of 5 of these severely ill patients will make a full recovery, stressing
the continued need for aggressive supportive care in these patients. Neurol Neuroimmunol
Neuroinflammation 2014;1:e9; doi: 10.1212/NXI.0000000000000009
GLOSSARY
ICP 5 intracranial pressure.
Figure 1
Table 1
Characteristics
Age, y
65 (4976)
Female
15/30 (50)
Predisposing conditions
15/30 (50)
Otitis/sinusitis
8/30 (27)
Immunocompromised state
6/30 (20)
Pneumonia
2/24 (8)
14/26 (54)
8/25 (32)
7/9 (78)
Temperature 38C
21/29 (70)
Neck stiffness
8/23 (35)
Seizures
10/30 (34)
130 (120159)
102 (98140)
9/26 (35)
Abnormal cranial CT
18/27 (67)
Generalized edema
8/27 (30)
Hydrocephalus
5/27 (19)
1/27 (4)
Subdural empyema/effusion
2/27 (7)
Mastoid opacification
7/27 (26)
Sinus opacification
4/27 (15)
15 (1020)
ESR, mm/h
12 (560)
221 (110327)
2,240 (16010,750)
10/27 (37)
Protein
5.5 (3.37.2)
0.01 (00.13)
CSF culture
Streptococcus pneumoniae
Adjunctive dexamethasone
26/30 (87)
25/29 (86)
Figure 2
Table 2
Characteristic
Systemic complications
Respiratory failure
15/25 (60)
Pneumonia
6/26 (23)
Hyponatremia
4/27 (15)
Neurologic complications
Cerebral infarction
3/30 (10)
Subdural empyema
2/30 (7)
Hearing impairment
4/30 (13)
Seizures
7/30 (23)
Outcome
GOS 1
18/30 (60)
GOS 2
GOS 3
2/30 (7)
GOS 4
3/30 (10)
GOS 5
Time to death, d
7/30 (23)
a
2 (122)
Causes of death
(A) Generalized cerebral edema with signs of pseudo-subarachnoid hemorrhage; (B) subdural empyema; (C) generalized cerebral edema indicating severe cerebral inflammation;
(D) hydrocephalus.
the Glasgow Outcome Scale and 2 as severely disabled requiring nursing home admission. All 11 patients presenting with either bilaterally absent
pupillary light responses or bilaterally absent corneal
reflexes died (table 3). Furthermore, all 9 patients with
signs of septic shock on admission died; septic shock
was defined as diastolic blood pressure ,60 mm Hg,
systolic blood pressure #90 mm Hg, or heart rate
$120 beats per minute. The mortality rate and frequency of sequelae were similar when considering only
patients who did not receive sedative medication on
admission (table e-2).
The causes of death in the 18 deceased patients
were as follows: extensive neurologic damage due
to meningitis (6 patients), acute brain herniation
shown on cranial imaging (4 patients), withdrawal
of care because of poor neurologic prognosis (2 patients; care was withdrawn 2 and 3 days after
admission), multiorgan failure or septic shock (2
patients each), and cardiac arrest or delayed cerebral thrombosis (1 patient each).15 Autopsy was
performed in 3 patients showing severe brain damage in all patients. In 1 patient venous sinus
thrombosis was identified that was not diagnosed
prior to autopsy.
4
6/18 (33)
Withdrawal of treatment
2/18 (11)
Brain herniation on CT
4/18 (22)
Multiorgan failure
2/18 (11)
Septic shock
2/18 (11)
Cardiac arrest
1/18 (6)
1/18 (6)
Neurologic sequelae
5/12 (42)
Cognitive impairment
Hemiparesis
Table 3
Unfavorable
outcomeb (n 5 20)
Seizures
3/10 (30)
7/20 (35)
Sedation
2/10 (20)
3/20 (15)
Characteristic
Symptoms and signs on admission
Septic shock
0/6
9/20 (45)
5/9 (56)
13/18 (72)
Generalized edema
2/9 (22)
6/18 (33)
Hydrocephalus
1/9 (11)
4/18 (22)
1/10 (10)
9/17 (53)
5.5 (2.77.1)
5.4 (3.98.2)
9/10 (90)
17/20 (85)
10/10 (100)
15/19 (79)
Abnormal cranial CT
CSF culture
Streptococcus pneumoniae
Adjunctive dexamethasone
ACKNOWLEDGMENT
We are indebted to all Dutch physicians who participated in the study. We
acknowledge research funding for the MeninGene study (Netherlands
Organization for Health Research and Development, the Academic Medical Center, and the European Research Council).
6.
7.
8.
9.
10.
11.
12.
13.
14.
STUDY FUNDING
This research has been supported by grants from the Netherlands Organization for Health Research and Development (Veni [916.76.023] and
Vidi [016.116.358] to D.v.d.B.; Veni [916.13.078] to M.C.B.), the Academic Medical Center (AMC Fellowship 2008 to D.v.d.B.), and the
European Research Council (ERC Starting Grant to D.v.d.B.).
15.
16.
DISCLOSURE
M.J. Lucas and A. van der Ende report no disclosures relevant to the
manuscript. M.C. Brouwer has received research support from the Dutch
Scientific Organization, The European Federation of Neurological Sciences, and the European Society of Clinical Microbiology and Infectious
Diseases. D. van de Beek is an editor for BMC Infectious Diseases and
Cochrane Acute Respiratory Infections Group and has received research
support from Omeros, The Academic Medical Center, and the European
Research Council. Go to Neurology.org/nn for full disclosures.
17.
18.
19.
20.
21.
22.
23.
24.